An article by Pavlos Stampoldis, Medical Affairs Director, Oncology, Ipsen. Renal cell carcinoma (RCC) has seen remarkable scientific progress over
Category: Oncology
A New Chapter for Children with pLGG
Sandra Silvestri, M.D., PhD, Executive Vice President and Chief Medical Officer, Ipsen. For the hundreds of children diagnosed with pediatric low-grade glioma (pLGG) across Europe each year, the journey
The role of biomarkers: how new modalities are making precision medicine a reality
By Christelle Huguet, EVP & Head of R&D, Ipsen For too long, modern medicine has treated diseases as if they
Shaping the next evolution of immuno-oncology
Mary Jane Hinrichs, Global Head of Early Development Redefining the next chapter of cancer innovation Working in early development, I
Moving NET Science Forward Together at ENETS 2026
An article by Dr Marius Tham, Director Global Medical Affairs, Ipsen The European Neuroendocrine Tumor Society (ENETS) 4 – 6
Progress for Families Facing Rare Childhood Brain Tumors
Written by: Christelle Huguet, Executive Vice President, Head of R&D Today marks an important moment for children and families affected by
We’re Ready for ASCO GU 2026: Advancing Knowledge Together
Vanessa Barue, Senior Medical Director, Medical Asset Lead, Global Medical Affairs Oncology As the global GU oncology community prepares to
United by Unique: Ipsen’s Commitment to Transforming Cancer Care
Roxanne Ferdinand, SVP, Head of Global Medical Affairs, Oncology As we prepare to mark World Cancer Day, which continues its
Get Men Talking: Ipsen Joins the Movember Movement for the Third Year
This Movember, Ipsen once again champions men’s health through our “Get Men Talking” podcast series — a heartfelt initiative encouraging
Lily May’s Story: Living With a Pediatric Low-Grade Glioma
Lily May, a vibrant and determined seven-year-old, loves gymnastics and golf. Yet, like many children living with pediatric low-grade glioma